Used as an intermediate in the synthesis of kinase inhibitors, particularly in the development of anticancer agents. It plays a key role in targeting specific tyrosine kinases involved in tumor growth and proliferation. Due to its functional groups and structural features, it enables selective binding and improved pharmacokinetic properties in drug candidates. Commonly employed in pharmaceutical research for optimizing lead compounds in oncology drug discovery programs.